Literature DB >> 12547044

Efficacy of gelclair in reducing pain in palliative care patients with oral lesions: preliminary findings from an open pilot study.

Marcello Innocenti, Giancarla Moscatelli, Silvano Lopez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12547044     DOI： 10.1016/s0885-3924(02)00524-9

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  10 in total

1.  Buccal alterations in diabetes mellitus.

Authors:  Carlos Antonio Negrato; Olinda Tarzia
Journal:  Diabetol Metab Syndr       Date:  2010-01-15       Impact factor: 3.320

Review 2.  [Topical pain therapy in oral mucositis: a systematic review].

Authors:  H Bornemann-Cimenti; S K Kobald; I S Szilagyi; A Sandner-Kiesling
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

3.  Current trends in the management of oral mucositis related to cancer treatment.

Authors:  Biswa Mohan Biswal
Journal:  Malays J Med Sci       Date:  2008-07

4.  The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other rinsing solutions in patients with oral mucositis after allogeneic stem cells transplantation.

Authors:  Samuel Vokurka; Jana Skardova; Renata Hruskova; Klara Kabatova-Maxova; Tomas Svoboda; Eva Bystricka; Katerina Steinerova; Vladimir Koza
Journal:  Med Sci Monit       Date:  2011-10

5.  Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.

Authors:  Claire Barber; Roy Powell; Annie Ellis; Julie Hewett
Journal:  Support Care Cancer       Date:  2006-11-28       Impact factor: 3.359

6.  Prevention and management of antineoplastic therapy induced oral mucositis.

Authors:  Afshan Bey; Syed S Ahmed; Bilal Hussain; Seema Devi; Sarwat H Hashmi
Journal:  Natl J Maxillofac Surg       Date:  2010-07

7.  A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.

Authors:  Gionata Fiorino; Giacomo Carlo Sturniolo; Fabrizio Bossa; Andrea Cassinotti; Antonio di Sabatino; Paolo Giuffrida; Silvio Danese
Journal:  Cells       Date:  2019-05-30       Impact factor: 6.600

8.  Non-inferiority study of the efficacy of two hyaluronic acid products in post-extraction sockets of impacted third molars.

Authors:  Hyunwoo Yang; Junghun Kim; Jihong Kim; Dongwook Kim; Hyung Jun Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2020-12-09

9.  Oral mucositis induced by anticancer treatments: physiopathology and treatments.

Authors:  D'Hondt Lionel; Lonchay Christophe; André Marc; Canon Jean-Luc
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

Review 10.  Oral toxicity produced by chemotherapy: A systematic review.

Authors:  Begonya Chaveli-López
Journal:  J Clin Exp Dent       Date:  2014-02-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.